Last Price$272.70.1%
Market Cap$19.4B
LTM Interest Income
$29.2M
YoY Growth
+2.1%
3Y CAGR
+288.0%
5Y CAGR
+40.2%
Stock quality & Intrinsic value
8/10
50.7% overvalued
Insulet Corporation Interest Income
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | $0.0 | $0.0 | $0.0 | $0.0 | $1,795.0K | $241.0K | $168.0K | $139.0K | $110.0K | $124.0K | $129.0K | $58.0K | $825.0K | $2,633.0K | $6,705.0K | $7,800.0K | $3,000.0K | $500.0K | $9,800.0K | $28.6M |
Overvalued or undervalued?
Check the intrinsic value for PODD
and see if it's the right time to invest.
Insulet Corporation (PODD) Interest Income comparison analysis
General
LTM Interest Income
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Insulet CorporationPODD
$29.2M
2.1%
288.0%
40.2%
Median Peer Set
$33.4M
(41.3%)
25.9%
10.1%
Abbott LaboratoriesABT
$344.0M
26.9%
100.0%
29.6%
Boston Scientific CorporationBSX
$107.0M
(52.0%)
199.1%
29.0%
DexCom, Inc.DXCM
$104.5M
(22.2%)
371.0%
31.7%
Koninklijke Philips N.V.PHG
$84.4M
73.4%
(19.2%)
(10.3%)
Edwards Lifesciences CorporationEW
$46.6M
(30.7%)
41.1%
45.3%
Align Technology, Inc.ALGN
$20.2M
17.2%
86.8%
10.1%
STERIS plcSTE
$8,768.0K
(75.2%)
10.6%
10.1%
Stryker CorporationSYK
$0.0
(100.0%)
N/A
N/A
Medtronic plcMDT
$0.0
(100.0%)
N/A
N/A
Zimmer Biomet Holdings, Inc.ZBH
$0.0
(100.0%)
N/A
N/A
PODD key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 0.0 0.0% | 0.1 0.0% | 3.7 7,226.0% | 13.4 265.1% | 36.1 169.7% | 66.0 83.1% | 97.0 46.8% | 152.3 57.0% | 211.4 38.8% | 247.1 16.9% | 288.7 16.9% | 263.9 (8.6%) | 367.0 39.1% | 463.8 26.4% | 563.8 21.6% | 738.2 30.9% | 904.4 22.5% | 1,098.8 21.5% | 1,305.3 18.8% | 1,697.1 30.0% |
| Cost of Goods Sold (COGS) | 0.0 | 1.5 | 15.7 | 25.7 | 40.6 | 47.7 | 53.2 | 85.5 | 119.0 | 134.7 | 145.4 | 130.6 | 155.9 | 186.6 | 193.7 | 257.9 | 322.1 | 346.7 | 499.7 | 537.2 |
% margin | 0.0 0.0% | (1.5) (2,960.0%) | (12.0) (327.5%) | (12.4) (92.4%) | (4.6) (12.7%) | 18.3 27.7% | 43.7 45.1% | 66.7 43.8% | 92.3 43.7% | 112.4 45.5% | 143.3 49.6% | 133.3 50.5% | 211.1 57.5% | 277.2 59.8% | 370.2 65.7% | 480.3 65.1% | 582.3 64.4% | 752.1 68.4% | 805.6 61.7% | 1,159.9 68.3% |
| Operating Expenses | 14.2 | 20.0 | 22.6 | 41.5 | 84.8 | 77.7 | 77.9 | 109.2 | 128.3 | 141.5 | 155.6 | 182.0 | 221.8 | 284.6 | 342.7 | 430.3 | 530.8 | 626.1 | 768.0 | 939.9 |
| Research & Development Expenses (R&D) | 9.0 | 10.8 | 8.1 | 10.4 | 13.1 | 13.2 | 16.6 | 21.9 | 24.4 | 21.8 | 27.9 | 43.2 | 55.7 | 74.5 | 88.6 | 129.7 | 146.8 | 160.1 | 180.2 | 205.0 |
| Selling, General & Administrative Expenses (SG&A) | 5.1 | 9.3 | 14.6 | 30.1 | 63.5 | 64.4 | 61.4 | 87.3 | 103.9 | 119.8 | 127.7 | 138.8 | 166.1 | 210.1 | 254.1 | 300.6 | 384.0 | 466.0 | 587.8 | 734.9 |
% margin | (14.2) 0.0% | (21.5) (43,010.0%) | (34.6) (945.8%) | (53.8) (402.6%) | (89.3) (247.8%) | (59.4) (89.9%) | (38.6) (39.8%) | (42.5) (27.9%) | (36.0) (17.0%) | (29.1) (11.8%) | (12.3) (4.3%) | (48.7) (18.5%) | (10.7) (2.9%) | (7.4) (1.6%) | 27.4 4.9% | 22.1 3.0% | (0.6) (0.1%) | 66.7 6.1% | (26.7) (2.0%) | 220.0 13.0% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 1.8 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.8 | 2.6 | 6.7 | 7.8 | 3.0 | 0.5 | 9.8 | 28.6 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 7.2 | 20.2 | 22.7 | 14.7 | 15.8 | 17.2 | 14.7 | 12.7 | 14.4 | 19.2 | 22.2 | 26.8 | 45.1 | 61.2 | 26.7 | 36.2 |
| Pre-tax Income | 0.0 | 0.0 | (35.5) | (53.5) | (92.8) | (79.5) | (61.2) | (57.0) | (51.7) | (44.9) | (51.4) | (61.4) | (26.8) | (26.6) | 5.2 | 14.5 | 9.7 | 20.5 | 9.8 | 214.6 |
% effective tax rate | (0.3) 0.0% | 0.1 0.0% | 1.3 (3.7%) | (0.3) 0.6% | 3.4 (3.7%) | (5.2) 6.6% | 21.9 (35.8%) | 0.1 (0.2%) | 0.2 (0.4%) | 0.1 (0.2%) | 0.1 (0.3%) | 0.2 (0.3%) | 0.4 (1.5%) | 0.3 (1.0%) | 1.9 37.0% | 2.9 20.0% | 2.9 29.9% | 3.7 18.0% | 5.2 53.1% | 8.3 3.9% |
% margin | (13.8) 0.0% | (21.6) (43,272.0%) | (36.0) (981.4%) | (53.5) (400.4%) | (92.8) (257.3%) | (79.5) (120.5%) | (61.2) (63.1%) | (57.2) (37.5%) | (51.9) (24.5%) | (45.0) (18.2%) | (51.5) (17.8%) | (73.5) (27.9%) | (28.9) (7.9%) | (26.8) (5.8%) | 3.3 0.6% | 11.6 1.6% | 6.8 0.8% | 16.8 1.5% | 4.6 0.4% | 206.3 12.2% |
| EPS | (47.64) | (70.95) | (99.10) | (3.21) | (3.36) | (2.68) | (1.54) | (1.22) | (1.08) | (0.83) | (0.93) | (1.29) | (0.51) | (0.46) | 0.06 | 0.19 | 0.11 | 0.25 | 0.07 | 2.96 |
| Diluted EPS | (47.64) | (70.95) | (39.19) | (3.21) | (3.36) | (2.68) | (1.54) | (1.22) | (1.08) | (0.83) | (0.93) | (1.29) | (0.50) | (0.46) | 0.05 | 0.19 | 0.10 | 0.25 | 0.07 | 2.80 |
% margin | (13.5) 0.0% | (20.3) (40,538.0%) | (32.0) (873.7%) | (48.9) (365.9%) | (81.2) (225.1%) | (53.9) (81.6%) | (33.4) (34.4%) | (35.8) (23.5%) | (24.8) (11.7%) | (16.2) (6.5%) | (24.4) (8.5%) | (36.3) (13.7%) | 1.3 0.3% | 6.5 1.4% | 49.8 8.8% | 77.0 10.4% | 110.3 12.2% | 139.6 12.7% | 109.5 8.4% | 323.6 19.1% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Insulet Corporation's Interest Income?
As of today, Insulet Corporation's last 12-month Interest Income is $29.2M, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is Insulet Corporation's Interest Income growth rate?
Over the last year, Insulet Corporation's Interest Income growth was 2.1%. The average annual Interest Income growth rates for Insulet Corporation have been 189.8% over the past three years, 40.2% over the past five years.
3) Is Insulet Corporation's Interest Income growth rate Good?
Over the last year, Insulet Corporation's Interest Income growth was 2.1%, which is higher than industry growth of (0.7%). It indicates that Insulet Corporation's Interest Income growth is Good.